MedPath

Comparison of the effect of Metoclopramide and intravenous acetaminophen on headache in patients that presenting to the Emergency Department of Imam Khomeini hospital of Urmia

Not Applicable
Conditions
Tension type headache
Condition 1: headache. Condition 2: headache. Condition 3: headache.
Migraine
Cluster headache syndrome
Registration Number
IRCT2014081817812N3
Lead Sponsor
rmia University of Medical Sciences -
Brief Summary

Introduction: Headache is the most common neurologic symptom among referees to the emergency department <br /> (ED), while the best treatment has not yet been found. Therefore, in the present study pain relief effects of metoclopramide and acetaminophen were compared in patients suffered acute primary headache. Methods: This study <br /> was a double-blind randomized clinical trial performed in Imam Khomeini Hospital, Urmia, Iran, through July to <br /> October 2014. All adult patients, with acute primary (migraine, tension type and cluster) headache referred to the <br /> ED were included in this study. Pain Severity was measured with 10 centimeters numeric rating scales. The patients <br /> were randomized in to two groups of intravenous (IV) metoclopramide (10 milligrams) and acetaminophen (1<br /> gram). Pain score, success rate, and complication of drugs were compared within administration time and 15, 30, <br /> 60, as well as 120 minutes after medication. Results: 100 patients were equally categorized in to two groups (mean <br /> age of 32 ± 13.2 years; 51.2% male). Initial pain score in metoclopramide and acetaminophen groups were 9.1 and <br /> 9.4, respectively (p=0.46). IV metoclopramide did not have any analgesic effect at 15 minutes, but had good effect <br /> at 30 minutes. While, the analgesic effect of acetaminophen initiated after 15 minutes. After 2 hours, both drugs <br /> had good treatment effect on primary headaches (p

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

all 15 -75 years patients with migrane, tension and cluster headache will be enrolled in this study.
exclusion criteria: allrgy to acetaminophen and metoclopramide

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduce in headache severity. Timepoint: Q/15 minute up to 120 minute. Method of measurement: 10 numerical visual analogue scales (VAS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath